Current Issue
Case Report
Salvage UCBT with Short-Term Melphalan-based Reduced-Intensity Conditioning for Primary Graft Failure after Upfront UCBT for Fulminant Aplastic Anemia
Volume 8 (2025) Issue 2 No.1 Pages 190-194
Submitted: October 3, 2024
Accepted: February 3, 2025
Published online: March 28, 2025
Issued online: May 25, 2025
Case Report
PYODERMA GANGRENOSUM WITH NON-PSEUDOMONAL ECTHYMA GANGRENOSUM IN MYELODYSPLASTIC SYNDROME TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Volume 8 (2025) Issue 2 No.2 Pages 195-199
Submitted: October 20, 2024
Accepted: February 24, 2025
Published online: May 9, 2025
Issued online: May 25, 2025
Original Article
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation
Volume 8 (2025) Issue 2 No.3 Pages 200-209
Submitted: November 15, 2024
Accepted: January 31, 2025
Published online: May 25, 2025
Issued online: May 25, 2025
Original Article
Tyrosine kinase inhibitor-related factors pre-disposing to post-transplant thrombotic microangiopathy in patients with CML and Ph+ acute leukemias
Volume 8 (2025) Issue 2 No.4 Pages 210-216
Submitted: October 21, 2024
Accepted: January 11, 2025
Published online: May 25, 2025
Issued online: May 25, 2025
Online First
Corrigendum to: Impact of the COVID-19 outbreak on the field of hematopoietic cell transplantation in the Asia-Pacific region: APBMT Activity Survey 2020/2021 [Blood Cell Therapy. 2024; 7(4): 129-137. doi:10.31547/bct-2024-020]
Published online: June 6, 2025
REAL-WORLD OUTCOMES OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE TREATED WITH RUXOLITINIB
Submitted: November 12, 2024
Accepted: January 14, 2025
Published online: June 27, 2025
Search
News

Online ISSN:2432-7026